Vimarsana
Biggest News Aggregation in the World

Cov Igg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cov Igg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cov Igg Today - Breaking & Trending Today

Study reveals seasonal MERS-CoV peaks in Kenyan camels and potential human transmission - Vimarsana News

Study reveals seasonal MERS-CoV peaks in Kenyan camels and potential human transmission

Researchers found biphasic peaks of MERS-CoV in dromedaries in Kenya, with evidence of serologic exposure among slaughterhouse workers, highlighting potential human transmission risks.

Researchers identify episodic MERS cases in Kenyan camels, evidence of infection in people - Vimarsana News

Researchers identify episodic MERS cases in Kenyan camels, evidence of infection in people

MERS-CoV antibody reactivity was identified in 7 of 48 camel-slaughterhouse workers (15%).

Source: umn.edu
Immune response after mild COVID - Vimarsana News

Immune response after mild COVID

In a recent study posted to the medRxiv* preprint server, researchers in Germany assessed the immunity elicited by a mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Cureus | SARS-CoV-2 Antibody Seroprevalence in Patients With Cancer on Systemic Antineoplastic Treatment in the First Wave of the COVID-19 Pandemic in Portugal - Vimarsana News

Cureus | SARS-CoV-2 Antibody Seroprevalence in Patients With Cancer on Systemic Antineoplastic Treatment in the First Wave of the COVID-19 Pandemic in Portugal

At the time of the first wave of the COVID-19 pandemic, patients with cancer were considered to be at high risk of serious illness and had a higher exposure risk since they needed frequent and nondeferrable hospital visits. Serological tests were not routinely used, and seroprevalence in this population was unknown. A single-center, cross-sectional study was developed to determine the seroprevalence of anti-SARS-CoV-2 antibodies (Abs) in patients with cancer undergoing systemic antineoplastic treatment. One hundred patients were consecutively recruited in a two-week period (6th-20th May 2020)...

Source: cureus.com